Efficacy of Series Double Continuous Hemodiafiltration Using Two Polymethyl Methacrylate Membrane Hemofilters for Patients With Hypercytokinemia
- 27 August 2013
- journal article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 18 (2) , 132-139
Abstract
Continuous hemodiafiltration using a hemofilter made from a membrane with cytokine adsorption properties is thought to be effective to remove cytokines in septic patients. In order to enhance cytokine removal capacity by increasing adsorption area, we devised a double polymethyl methacrylate continuous hemodiafiltration method, which involves serial connection of two polymethyl methacrylate membrane hemofilters, and we report clinical efficacy with this method. Of 74 patients who underwent continuous hemodiafiltration and had interleukin-6 blood levels measured during their ICU stay between March 2010 and June 2012, 13 patients with hypercytokinemia (interleukin-6 blood level >900 pg/mL) underwent series double continuous hemodiafiltration to be treated for hypercytokinemia. Cytokine reduction rate and clinical efficacy were compared between those 13 patients and those with a similar pathological condition who underwent continuous hemodiafiltration using the single polymethyl methacrylate membrane hemofilter. Interleukin-6 blood levels 6 h after continuous hemodiafiltration initiation increased in the single continuous hemodiafiltration group from 17040 ± 33660 pg/mL to 26290 ± 66250 pg/mL; however, interleukin-6 blood level significantly decreased in the series double continuous hemodiafiltration group from 20220 ± 29120 pg/mL to 6790 ± 10820 pg/mL. Interleukin-6 reduction rate during the period between initiation and 6 h after initiation of continuous hemodiafiltration was significantly higher in the series double continuous hemodiafiltration group(63.5 ± 38.9%) compared to that of the single continuous hemodiafiltration group (-342 ± 1306%)(P = 0.039). Series double continuous hemodiafiltration using two polymethyl methacrylate hemofilters with cytokine adsorbing capacity is effective to remove cytokine in hypercytokinemic septic patients.Keywords
This publication has 20 references indexed in Scilit:
- Sustained High-Efficiency Daily Diafiltration Using a Mediator-Adsorbing Membrane (SHEDD-fA) in the Treatment of Patients with Severe Sepsis2011
- Polymethylmethacrylate Membrane with a Series of Serendipity2011
- Comparison of Interleukin-6 Removal Properties among Hemofilters Consisting of Varying Membrane Materials and Surface Areas: An in vitro StudyBlood Purification, 2010
- Membrane Materials for Blood Purification in Critical Care2010
- Non-Renal Indications for Continuous Renal Replacement Therapy: Current Status in Japan2010
- Treatment of Severe Sepsis and Septic Shock by CHDF Using a PMMA Membrane Hemofilter as a Cytokine Modulator2010
- Online CHDF System: Excellent Cost-Effectiveness for Continuous Renal Replacement Therapy with High Efficacy and Individualization2010
- Indications for Blood Purification in Critical Care2010
- Terminology and Classification of Blood Purification in Critical Care in Japan2010
- High-Volume Hemofiltration in Sepsis and SIRS: Current Concepts and Future ProspectsBlood Purification, 2009